High potency improvements to weak aryl uracil HCV polymerase inhibitor leads.
Donner P, Randolph JT, Huang P, Wagner R, Maring C, Lim BH, Colletti L, Liu Y, Mondal R, Beyer J, Koev G, Marsh K, Beno D, Longenecker K, Pilot-Matias T, Kati W, Molla A, Kempf D.
Donner P, et al. Among authors: kempf d.
Bioorg Med Chem Lett. 2013 Aug 1;23(15):4367-9. doi: 10.1016/j.bmcl.2013.05.078. Epub 2013 Jun 4.
Bioorg Med Chem Lett. 2013.
PMID: 23791079